Founder Directory
Built by Keitoto
Founders1
Known for these resultsRole0%Role is parsed from founder titles in yc.db. Known for 0% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School100%School is matched from bios, case-sensitive for acronyms. 100% of these rows have at least one match.
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Beth HoffmanOrigami Therapeutics, Inc.FounderWinter 2022HealthcareSan Diego, United States4https://x.com/bethjhoffman
Showing 1–1 of 1 founders
Beth Hoffman
Founder·Origami Therapeutics, Inc.
PRIMARY INFO
RoleFounder· not in title
Team size4
BatchWinter 2022
LocationSan Diego, United States
Company statusActive
StageEarly
BIO
At Origami Therapeutics, Dr. Hoffman is creating a new approach to drug discovery for neurodegenerative diseases. Prior to Origami, she was a Research & Development executive at Vertex Pharmaceuticals, Amgen and Eli Lilly. She has made major contributions to >30 clinical programs in neurology, pain and psychiatry and to four marketed drugs for Cystic Fibrosis. Dr. Hoffman received her A.B. in Molecular Biology from Wellesley College and a Ph.D. in Cell Biology from the Johns Hopkins University.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhD
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration
IndustryHealthcare
Websiteorigamitherapeutics.com
Team size4
LocationSan Diego, United States
BatchWinter 2022
